Skip to main content Accessibility help
×
Hostname: page-component-77f85d65b8-v2srd Total loading time: 0 Render date: 2026-04-14T09:50:54.115Z Has data issue: false hasContentIssue false

16 - Hematological malignancies

Published online by Cambridge University Press:  13 August 2009

By
Melissa Friedman  and
Mercedes Fernandez
Edited by
Christina A. Meyers  and
James R. Perry
Christina A. Meyers
Affiliation:
University of Texas, M. D. Anderson Cancer Center
James R. Perry
Affiliation:
University of Toronto
Get access

Summary

Introduction

Development of effective treatments for cancer has significantly improved survival rates for hematological cancer patients. For example, in 1964 the 5-year survival rate for acute lymphoblastic leukemia (ALL) was 3%; in 1995–2001, it was 86% (Leukemia and Lymphoma Society, 2005; Ries et al., 2005). However, survival is often associated with negative effects on cognitive functioning which interfere with patients' current and future functional status.

In patients with hematological malignancies, risk factors for cognitive disorders are present during all stages of the disease and treatment process. Risk factors include cancer treatments, anemia and fatigue, immune response activity, central nervous system (CNS) involvement of the primary malignancy (especially in the case of ALL), disease and treatment complications affecting the CNS such as infection, hemorrhage, degeneration and leukoencephalopathy, and cognitive and psychiatric disorders that occur in the general population independent of having cancer.

Information on the long-term neuropsychological effects of cancer therapies is an important component of not only the informed consent process, but also the treatment planning process. In the risk-benefit analysis for selecting treatment, survival rates alone may be insufficient because some treatments are associated with significant depletion of cognitive and functional abilities.

Neurological Complications Independent of Cognitive Deficits

Neurological complications, independent of cognitive complaints, are common in hematological cancer patients. Neurological complications have been reported in 11%–65% of hematopoietic stem cell transplantation (HSCT) patients (Faraci et al., 2002; Gallardo et al., 1996; Graus et al., 1996; Harder et al., 2002; Sostak et al., 2003) and may be the main cause of death in 8.5%–26% of recipients (Faraci et al., 2002; Gallardo et al., 1996; Snider et al., 1994; Sostak et al., 2003).

Information

Type
Chapter
Information
Cognition and Cancer , pp. 228 - 238
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Ahles, TA, Saykin, A (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest 19(8): 812–820.CrossRefGoogle Scholar
Ahles, TA, Tope, DM, Furstenberg, C, Hann, D, Mills, L (1996). Psychologic and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol 14: 1457–1462.CrossRefGoogle ScholarPubMed
Ahles, TA, Saykin, AJ, Furstenberg, CTet al. (2002). Neuropsychologic impact of standard dose systemic chemotherapy in long term survivors of breast cancer and lymphoma. J Clin Oncol 20: 485–493.CrossRefGoogle ScholarPubMed
Ahles, TA, Saykin, AJ, Noll, WWet al. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12: 612–619.CrossRefGoogle ScholarPubMed
Anderson-Hanley, C, Sherman, ML, Riggs, R, Agocha, VB, Compas, BE (2003). Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9: 967–982.CrossRefGoogle ScholarPubMed
Andrykowski, MA, Schmitt, FA, Gregg, ME, Brady, MJ, Lamb, DG, Henslee-Downey, PJ (1992). Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer 70: 2288–2297.3.0.CO;2-M>CrossRefGoogle ScholarPubMed
Andrykowski, MA, Carpenter, JS, Greiner, CBet al. (1997). Energy level and sleep quality following bone marrow transplantation. Bone Marrow Transplant 20: 669–679.CrossRefGoogle ScholarPubMed
Antonini, G, Ceschin, V, Morino, Set al. (1998). Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 50: 1441–1445.CrossRefGoogle ScholarPubMed
Antunes, NL, Small, TN, George, D, Farid, B, Lis, E (1999). Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 20: 241–243.CrossRefGoogle Scholar
Antunes, NL, Boulad, FL, Prasad, V, Rosenblum, M, Lis, E, Souweidane, M (2000). Rolandic encephalopathy and epilepsia partialis continua following bone marrow transplant. Bone Marrow Transplant 26: 917–919.CrossRefGoogle ScholarPubMed
Armstrong, FD (2001). Acute and long term neurodevelopmental outcomes in children following bone marrow transplantation. Front Biosci 6: 6–12.CrossRefGoogle ScholarPubMed
Armstrong, FD (2005). Thalassemia and learning: neurocognitive functioning in children. Ann N Y Acad Sci 1054: 283–289.CrossRefGoogle ScholarPubMed
Atkinson, K, Biggs, J, Darveniza, P, Boland, J, Concannon, A, Dodds, A (1984). Cyclosporine associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 38: 34–37.CrossRefGoogle ScholarPubMed
Bartha, AI, Foster-Barber, A, Miller, SPet al. (2004). Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome. Pediatr Res 56(6): 960–966.CrossRefGoogle Scholar
Brown, WS, Marsh, JT, Wolcott, Det al. (1991). Cognitive function, mood and P3 latency: effects of the amelioration of anemia in dialysis patients. Neuropsychologia 29: 35–45.CrossRefGoogle ScholarPubMed
Bruner, AB, Joffe, A, Duggan, AK, Casella, JF, Brandt, J (1996). Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 348: 992–996.CrossRefGoogle ScholarPubMed
Buizer, AI, Sonneville, LMJ, Heuvel-Eibrink, MM, Veerman, AJP (2005). Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer 45: 281–290.CrossRefGoogle ScholarPubMed
Buizer, AI, Sonneville, LMJ, Heuvel-Eibrink, MM, Veerman, AJP (2006). Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor. Cancer 106: 2067–2075.CrossRefGoogle ScholarPubMed
Butler, RW, Copeland, DR (2002). Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc 8: 115–124.CrossRefGoogle ScholarPubMed
Capuron, L, Gumnick, JF, Musselman, DL, Lawson, DHet al. (2002). Neurobehavioral effects of interferon alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26: 643–652.CrossRefGoogle ScholarPubMed
Brabander, C. Cornelissen, J, Smitt, P, Vecht, CJ, Bent, MJ (2000). Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 68: 36–40.CrossRefGoogle ScholarPubMed
Espy, KA, Moore, IM, Kaufmann, PM, Kramer, JH, Matthay, K, Hutter, JJ (2001). Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. J Pediatr Psychol 26: 1–9.CrossRefGoogle ScholarPubMed
Faraci, M, Lanino, E, Dini, Get al. (2002). Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 59: 1895–1904.CrossRefGoogle ScholarPubMed
Friedman, MA (2001). Neuropsychological functioning in hematopoietic stem cell transplantation. Dissertation Abstracts. Houston, TX: University of Houston.Google Scholar
Gallardo, D, Ferra, C, Berlanga, JJet al. (1996). Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 18: 1135–1139.Google ScholarPubMed
Graus, F, Saiz, A, Sierra, Jet al. (1996). Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia. Neurology 46: 1004–1009.CrossRefGoogle ScholarPubMed
Harder, H, Cornelissen, JJ, Gool, ARet al. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer 95: 183–192.CrossRefGoogle ScholarPubMed
Harder, H, Gool, AR, Cornelissen, JJet al. (2005). Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: a comparative study. Eur J Cancer 41: 1007–1016.CrossRefGoogle ScholarPubMed
Harder, H, Duivenvoorden, HJ, Good, ARet al. (2006). Neurocognitive functions and quality of life in haematological patients receiving haematopoietic stem cell grafts: a one-year follow-up pilot study. J Clin Exp Neuropsychol 28: 283–293.CrossRefGoogle ScholarPubMed
Hill, , Ciesielski, KT, Hart, BL, Jung, RE (2004). MRI morphometric and neuropsychological correlates of long-term memory in survivors of childhood leukemia. Pediatr Blood Cancer 42: 611–617.CrossRefGoogle ScholarPubMed
Jacobsen, PB, Garland, LL, Booth-Jones, Met al. (2004). Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage 28: 7–18.CrossRefGoogle ScholarPubMed
Kaemingk, KL, Carey, ME, Moore, IM, Herzer, M, Hutter, JJ (2004). Math weaknesses in survivors of acute lymphoblastic leukemia compared to healthy children. Child Neuropsychol 10: 14–23.Google ScholarPubMed
Kim, S-D, Kim, H-S (2005). Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patieints. J Clin Nurs 14: 51–55.CrossRefGoogle Scholar
Kingma, A, Dommelen, RI, Mooyaart, EL, Wilmink, JT, Deelman, BG, Kamps, WA (2002). No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study. J Pediatr Hematol-Oncol 24: 106–114.CrossRefGoogle ScholarPubMed
Krajinovic, M, Robaey, P, Chiasson, Set al. (2005). Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL. Pharmacogenomics 6: 293–302.CrossRefGoogle ScholarPubMed
Kramer, JH, Crittenden, MR, DeSantes, K, Cowan, MJ (1997). Cognitive and adaptive behavior one and three years following bone marrow transplantation. Bone Marrow Transplant 19: 607–613.CrossRefGoogle Scholar
Kronfol, Z, Remick, DG (2000). Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157: 683–694.CrossRefGoogle ScholarPubMed
Langer, T, Martus, P, Ottensmeier, H, Hertzberg, H, Beck, JD, Meier, W (2002). CNS late-effects after ALL therapy in childhood. Part III: Neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol 38: 320–328.CrossRefGoogle ScholarPubMed
Lee, BN, Dantzer, R, Langley, KEet al. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11: 279–292.CrossRefGoogle ScholarPubMed
Leukemia and Lymphoma Society (2005). Facts 2005. Available online at www.leukemia-lymphoma.org, accessed 4 April 2008.
Mancuso, A, Migliorino, M, Santis, S, Saponiero, A, Marinis, F (2006). Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 17(1): 146–150.CrossRefGoogle Scholar
Marsh, JT, Brown, WS, Wolcott, Det al. (1991). rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int 39: 155–163.CrossRefGoogle ScholarPubMed
Martin-Lester, M (1997). Cognitive function in dialysis patients. ANNA J 24: 359–365.Google ScholarPubMed
Mennes, M, Stiers, P, Vandenbussche, Eet al. (2005). Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer 44: 478–486.CrossRefGoogle ScholarPubMed
Metallinos-Katsaras, E, Valassi-Adamn, E, Dewey, KG, Lonnerdal, B, Stamoulakatou, A, Pollitt, E (2004). Effect of iron supplementation on cognition in Greek preschoolers. Eur J Clin Nutri 58: 1532–1542.CrossRefGoogle ScholarPubMed
Meyers, CA (1999). Mood and cognitive disorders in cancer patients receiving cytokine therapy. In Dantzer, R (ed.) Cytokines, Stress and Depression. New York: Kluwer Academic/Plenum Publishers.Google Scholar
Meyers, CA, Abbruzzese, JL (1992). Cognitive functioning in cancer patients: effect of previous treatment. Neurology 42: 434–436.CrossRefGoogle ScholarPubMed
Meyers, CA, Valentine, AD (1995). Neurological and psychiatric adverse effects of immunological therapy. CNS Drugs 3: 56–68.CrossRefGoogle Scholar
Meyers, CA, Scheibel, RS, Forman, AD (1991). Persistent neurotoxicity of systematically administered interferon alpha. Neurology 41: 672–676.CrossRefGoogle Scholar
Meyers, CA, Weitzner, M, Byrne, K, Valentine, A, Champlin, RE, Przepiorka, D (1994). Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 12: 820–826.CrossRefGoogle ScholarPubMed
Meyers, CA, Albitar, M, Estey, E (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104: 788–793.CrossRefGoogle ScholarPubMed
Mulhern, RK, Butler, RW (2004). Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabit 7: 1–14.CrossRefGoogle ScholarPubMed
Mulhern, RK, Ochs, J, Fairclough, D (1992) Deterioration of intellect among children surviving leukemia: IQ test changes modify estimates of treatment toxicity. J Consult Clin Psychol 60: 477–480.CrossRefGoogle ScholarPubMed
Mulhern, RK, Khan, RB, Kaplan, Set al. (2004). Short term efficacy of methylphenidate: a randomized double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 22: 4795–4803.CrossRefGoogle ScholarPubMed
Nissenson, AR (1992). Epoetin and cognitive function. Am J Kidney Dis 20: 21–24.Google ScholarPubMed
Oeffinger, KC, Hudson, MM (2004). Long term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin 54: 208–236.CrossRefGoogle ScholarPubMed
Padovan, CS, Yousry, TA, Schleuning, M, Holler, E, Kolb, H-J, Straube, A (1998). Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol 43: 627–633.CrossRefGoogle ScholarPubMed
Pavol, MA, Meyers, CA, Rexer, JL, Valentine, AD, Mattis, PJ, Talpaz, M (1995). Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology 45: 947–950.CrossRefGoogle ScholarPubMed
Peper, M, Steinvorth, S, Schraube, Pet al. (2000). Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors. Int J Radiat Oncol Biol Phys 46(2): 303–311.CrossRefGoogle Scholar
Phipps, S, Dunavant, M, Srivastava, DK, Bowman, L, Mulhern, RK (2000). Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 18 (5): 1004–1011.CrossRefGoogle Scholar
Recht, L, Mrugala, M (2003). Neurologic complications of hematologic neoplasms. Neurol Clin 21: 87–105.CrossRefGoogle ScholarPubMed
Reichenberg, A, Yirmiya, R, Schuld, Aet al. (2001). Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58: 445–452.CrossRefGoogle ScholarPubMed
Richard, F, Amouyel, P (2001). Genetic susceptibility factors for Alzheimer's disease. Eur J Pharmacol 412: 1–12.CrossRefGoogle ScholarPubMed
Ries, LAG, Eisner, MP, Kosary, CLet al. (2005). SEER Cancer Statistics Review, 1975–2002. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2002/, based on November 2004 SEER data submission, posted to the SEER website, 2005.Google Scholar
Rodgers, J, Marckus, R, Kearns, P, Windebuck, K (2003). Attentional ability among survivors of leukaemia treated without cranial irradiation. Arch Dis Child 88: 147–150.CrossRefGoogle ScholarPubMed
Scheibel, RS, Valentine, AD, O'Brien, S, Meyers, CA (2004). Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci 16: 185–191.CrossRefGoogle ScholarPubMed
Seymour, JF, Talpaz, M, Hagemeister, FB, Cabanillas, F, Kurzrock, R (1997). Clinical correlates of elevated serum levels of interleukin-6 in patients with untreated Hodgkin's disease. Am J Med 102: 21–28.CrossRefGoogle ScholarPubMed
Shah, AK (1999). Cyclosporine A neurotoxicity among bone marrow transplant recipients. Clin Neuropharmacol 22: 67–73.CrossRefGoogle ScholarPubMed
Singh, NP, Sahni, V, Wadhwa, Aet al. (2006). Effect of improvement in anemia on electroneurophysiological markers (P300) of cognitive dysfunction in chronic kidney disease. Hemodial Int 10(3): 267–273. Erratum in Hemodial Int 2006; 10(4): 408.CrossRefGoogle Scholar
Snider, S, Bashir, R, Bierman, P (1994). Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology 44: 681–684.CrossRefGoogle ScholarPubMed
Sostak, P, Padovan, CS, Yousry, TA, Ledderose, G, Kolb, HJ, Straube, A (2003). Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60: 842–848.CrossRefGoogle ScholarPubMed
Spiegler, BJ, Kennedy, K, Maze, Ret al. (2006). Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 24: 3858–3864.CrossRefGoogle ScholarPubMed
Stalfelt, AM, Zettervall, O (1997). Quality of life in young patients with chronic myelocytic leukaemia during intensive treatment including interferon. Leukemia Res 21(8): 775–783.CrossRefGoogle Scholar
Stivelman, JC (2000). Benefits of anaemia treatment on cognitive function. Nephrol Dial Transplant 15(3): 29–35.CrossRefGoogle Scholar
Temple, RM, Deary, IJ, Winney, RJ (1995). Recombinant erythropoietin improves cognitive function in patients maintained on chronic ambulatory peritoneal dialysis. Nephrol Dial Transplant 10: 1733–1738.Google ScholarPubMed
Uckan, D, Cetin, M, Yigitkanli, Iet al. (2005). Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplant 35: 71–76.CrossRefGoogle ScholarPubMed
Velu, T, Debusscher, L, Stryckmans, PA (1985). Cyclosporin-associated fatal convulsions. Lancet Jan 26; 1(8422): 219.CrossRefGoogle Scholar
Vezmer, S, Becker, A, Bode, U, Jaehde, U (2003). Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 49: 92–104.CrossRefGoogle Scholar
Waber, DP, Tarbell, NJ, Fairclough, Det al. (1995). Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 13: 2490–2496.CrossRefGoogle ScholarPubMed
Waber, DP, Shapiro, BL, Carpentieri, SCet al. (2001). Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia. Cancer 92: 15–22.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Walter, T (1994). Effect of iron-deficiency anaemia on cognitive skills in infancy and childhood. Baillieres Clin Haematol 7: 815–827.CrossRefGoogle ScholarPubMed
Watkins, LR (2000). The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 51: 29–57.CrossRefGoogle ScholarPubMed
Weiskopf, RB, Toy, P, Hopf, HWet al. (2005). Acute isovolemic anemia impairs central processing as determined by P300 latency. Clin Neurophysiol 116: 1028–1032.CrossRefGoogle ScholarPubMed
Weiskopf, RB, Feiner, J, Hopf, Het al. (2006). Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 104: 911–920.CrossRefGoogle ScholarPubMed
Wilson, RW, Taliaferro, , Jacobsen, PB (2006). Pilot study of a self-administered stress management and exercise intervention during chemotherapy for cancer. Support Care Cancer 14: 928–935.CrossRefGoogle ScholarPubMed

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the PDF of this chapter is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×